Red light therapy masks: what the research actually reveals about ‘clinically proven’ claims

In 2024, red light therapy masks generated more than 70 million TikTok views, according to a peer-reviewed audit of the field. Consumers are strapping LED masks to their faces in pursuit of flawless skin. Devices cost anywhere from £100 to over £3,500.

Behind these steep prices, brands promise to erase wrinkles and rejuvenate ageing skin. One 2023 study by Christian Dior sits at the centre of the most expensive claims. The same pattern appears in No7’s Future Renew serum, which relies on a single manufacturer-funded trial to support its ‘97% saw a difference’ claim.

The underlying science is photobiomodulation: the use of specific light wavelengths to trigger biological changes in skin tissue. The question is whether a single manufacturer-funded study of 20 volunteers can carry the weight of the phrase “clinically proven.”

Table of Contents

What the Dior study actually found

In June 2023, Skin Research and Technology published a study on the Skin Light Dior mask. Its lead researcher, Virginie Couturaud, is employed by Christian Dior. The brand retails the device for €4,000 and calls its results “clinically proven.”

The study recruited 20 healthy volunteers — 15 women and five men — aged between 45 and 70. However, the paper’s own abstract describes the sample as “20 healthy Caucasian women.” Participants used the device twice weekly for three months, at 12 minutes per session.

Eight outcomes were measured using specific clinical instruments. Skin firmness was assessed using a Cutometer, a device that measures the mechanical properties of skin. Dermal density was assessed by ultrasound, complexion evenness by chromametry (an instrument that measures skin colour and tone), and pore diameter by macrophotography.

The remaining measures — crow’s feet depth, facial sagging, skin roughness and sebum levels — were scored clinically or by instrument. Volunteer satisfaction was assessed via self-administered questionnaire at the study’s end.

After three months, the researchers recorded a 38.3% decrease in crow’s feet depth and a 47.7% increase in dermal density. Skin firmness, measured by the R0 value, decreased by 23.6%. Sebum measurements were conducted on only ten of the 20 volunteers: those presenting with mixed to oily skin.

The researchers concluded that these results “confirm the interest of using photobiomodulation to reverse the visible signs of aging.” Improvements persisting one month after stopping were described as “a sign of lasting structural and functional rejuvenation of the skin.”

How to read a ‘clinically proven’ claim

The phrase ‘clinically proven’ carries a specific meaning in medical research. It implies, at minimum, two groups: one receiving the active treatment, one receiving a sham equivalent. The Dior study contained none of these elements — no control group, no sham device.

The study was conducted by Dior’s own employee on Dior’s own commercial product. Co-author Frederic Granotier is affiliated with Lucibel Group, the manufacturer of the tested device. The conflict of interest statement declares no competing interests.

Without a comparison group, there is no way to separate the effects of red light from the placebo effect. The placebo effect describes the documented tendency for participants to report improvement simply from believing a treatment is working. An expensive device used consistently over several months is precisely the kind of intervention where expectation alone can generate reported results.

This missing baseline is exactly what Dr David Robert Grimes identified in his 2025 independent audit. As a radiation physicist at Trinity College Dublin, he highlighted the Dior research’s lack of a non-light control group.

The problem extends well beyond one luxury brand. Grimes found that one third of all visible light studies lacked a control group entirely. Assessors often knew which patients received the treatment, introducing severe experimental bias. The same divergence between industry-funded and independent research has built the collagen supplements market.

Grimes also exposed a deeper problem with dosage. The studies he reviewed used wavelengths and treatment times that differed wildly. No studies reported any dose validation, making it impossible for other scientists to replicate the findings.

What a sham-controlled trial actually found

In February 2025, a multi-centre South Korean trial applied the design the Dior study lacked. It was double-blind and sham-controlled — meaning neither participants nor assessors knew who received the active device. Half the 60 participants were assigned a mask that appeared identical but emitted minimal light.

Independent raters assessed outcomes without knowing which group each participant belonged to. They recorded an 86.2% improvement rate in the active group — a 69.5% difference against the sham control.

Yet this successful protocol was significantly more intensive than the twice-weekly Dior routine. Participants used the Korean device five times a week for 12 weeks.

	Dior / Couturaud 2023	Park et al. 2025
Sample size	20	60 (59 analysed)
Control design	No control group	Double-blind sham device
Session frequency	2 × weekly	5 × weekly
Outcome assessment	Self-questionnaire	Independent raters

In late 2025, the Advertising Standards Authority banned four LED mask brands for making unlawful medical claims. Britain’s medical device regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), had no LED face masks on its public registration database — a finding confirmed by a BBC investigation that month. These enforcement actions reflect the commercial architecture that makes unsubstantiated claims profitable regardless of the evidence base.

The reality of home light therapy

The independent expert consensus is not that red light therapy is fraudulent. It is that the claims attached to consumer masks go far beyond what the science currently supports.

Dr Justine Kluk, a consultant dermatologist and British Skin Foundation spokesperson, identified precisely where the evidence breaks down. “There is even less data available for at-home LED masks for treating these skin conditions,” she told The Independent, “and out of the handful of studies they are published by the companies that sell them, so there is bias in interpreting the results — they probably wouldn’t publish data that showed they didn’t work.”

Dr Jonathan Kentley, also a British Skin Foundation spokesperson, drew the line at the specific claim this article investigates. He stated there is “insufficient evidence” to claim at-home LED masks reduce wrinkles. That conclusion sits in direct contradiction to a product page calling the same category “clinically proven.”

Dr Daniel Barolet, a photobiomodulation researcher at McGill University and a proponent of the underlying science, acknowledged “a lot of hype in the industry.” He noted that scientists are still refining the ideal wavelength, intensity and proximity for each health goal. His estimate for cumulative visible results on normally ageing skin: five to ten years of consistent use.

The science of light therapy is real, but the consumer evidence remains fractured. A single uncontrolled study of 20 volunteers cannot prove lasting structural rejuvenation. Until brands fund independent, sham-controlled trials, “clinically proven” remains a marketing slogan rather than a scientific fact.